What is CAR T cell therapy? Learn about how this immunotherapy works

CAR T cell therapy aims to boost the immune system to attack tumor cells Cell therapies, sometimes called “living therapies,” are an especially promising and rapidly growing area of cancer research. One approach that’s been pioneered by Memorial Sloan Kettering researchers, led by investigator Michel Sadelain, is called CAR T cell immunotherapy. This type of […]

Read full story

The European MDS Registry: learning about the ‘real’ MDS patients

Research FOR Patients For an informed and empowered opinion and an improved consultation Have you made your clinical paper accessible yet? What is a clinical Registry? In order to develop new drugs to treat MDS, clinical trials are mandatory, typically testing the new drug against the treatment that is considered to be the standard at […]

Read full story

Clinical data on new medicines is now open to patients and researchers

Researchers and patients can access thousands of pages submitted by pharmaceutical companies As of the 20th of October, the European Medicines Agency (EMA) gives open access to clinical reports for new medicines authorised in the European Union. For every new medicine, citizens, including researchers and academics, will be able to directly access thousands of pages […]

Read full story

Help the NHS and Leukaemia CARE improve their services

Care and Treatment for Blood Cancer: Patient Survey Leukaemia Care is asking patients to fill in a new questionnaire about their care and treatment for blood cancer. Its purpose is to provide information, which will help the NHS and Leukaemia CARE to monitor and improve the quality of health services for future patients with blood […]

Read full story

Stored Blood is as Good as Fresh Blood Reveals Study

Fresher is not better It’s been long thought that when blood transfusions are needed, it may be best to use the freshest blood, but McMaster University researchers have led a large international study proving that it is not so. The study of almost 31,500 patients at six hospitals in four countries showed that having a […]

Read full story

CAMELLIA

Investigational drugs: Anti-CD47 monoclonal antibody, Hu5F9-G4 (target therapy that blocks the growth of cancer cells) For what level of MDS severity risk: What subtype of MDS: Patients with Acute Myeloid Leukemia that has returned after a period of improvement (relapsed) or has not responded to previous treatment (refractory). Read More

Read full story

Further cuts for stem cell transplants – for yet another rare blood cancer

24 February 2017: NHS England reinstates funding to 2nd stem cell transplants thanks to your support. Read More Here Telegraph article from Saturday 13th of August– with further details about NHS England funding issues. Patients with WM (Waldenstroem) are denied live-saving stem cell transplant treatment You may have read or heard about the recent legal […]

Read full story

Patients condemned to die: NHS denies funding for 2nd stem cell transplant

Anthony Nolan's Trust urges the Government to ensure every patient can access the treatment they need Update 24 February 2017: NHS England reinstates funding to 2nd stem cell transplants thanks to your support! Read More Here Stem cell transplants help cancer patients replace damaged blood cells Procedure costs the National Health Service between £50,000 and £120,000  […]

Read full story

Sharon Berger Transplant Update

Sharon Berger, who celebrated her 65th birthday only a few weeks ago, has received devastating news when a routine blood test showed that, after three years, her leukemia has returned. Sharon needs now a new stem cell donor. A suitable donor will most likely be someone with Ashkenazi Jewish heritage, so Anthony Nolan is calling for donors from this community: […]

Read full story
Free donations by shopping